2022 has been an incredible year here at IBEX.
We’ve taken major strides toward transforming osteoporosis detection and diagnosis and we’re truly excited about the road ahead. 2023 is looking to be a transformative year for IBEX so make sure to watch this space.
We look forward to sharing news of our latest developments in the New Year, but for now, we’d like to say a huge thank you for your continued support and we’ll see you next year!
After participating in an IBEX BH clinical study, Susan discovered that she had developed a heightened risk of suffering a fracture. Following an official diagnosis of osteopenia from her doctor, Susan has since taken vital steps to improve her bone health such as taking up running, changing her diet, and taking vitamin D and calcium…
Lisa March(Quality and Office Manager) Lisa is passionate about everything Quality and Regulatory, ensuring compliance with applicable medical device regulations, guidance, and standards, whilst staying abreast of changes in the regulatory climate. Lisa is currently studying for a Masters in Regulatory Affairs. I asked Lisa a few questions to find out a little more about…
So why tea? Research suggests that certain compounds found in tea, such as flavonoids and polyphenols, may contribute to bone density and strength. These elements are believed to play a role in the bone remodeling process, where old bone tissue is replaced by new, healthier tissue. Awareness is the first step to change There are…
With a PhD in Mathematics and an MMath degree, our research scientist Tim Whitbread has an impressive academic background. At IBEX, Tim’s role involves applying his acquired knowledge into statistical techniques to develop and improve the core algorithms in the company’s software. To learn a little more about Tim, his interests, and his ambitions, I…
IBEX Trueview® software uses physics modelling and AI methods to return an accurate measurement of bone health from standard DR scans. The software aims to improve patient outcomes and reduce healthcare costs through increased identification of patients at risk of fracture. Opportunistic Fracture Risk Prediction Trueview’s output is correlated to DXA-derived areal bone mineral density (aBMD) and can therefore be combined with other…
IBEX BH returns an accurate measurement of bone health from standard DR scans, providing a much-needed tool for addressing the underdiagnosis of osteoporosis. IBEX is excited to be showcasing this technology at ECR 2023 (March 1-5). The unique IBEX BH software opportunistically identifies patients at heightened risk of fracture by returning DXA outputs, including areal bone…
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
